Back
Speaker illustration

Mr Ulises Lopez

Bellvitge University Hospital, Hospitalet De Llobregat (Spain)

Member of:

Heart Failure Association of the ESC

Presentations

Differences in patients with early and late toxic cardiomyopathy post-chemotherapy: characteristics and prognosis

Event: Heart Failure 2019

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources